The Recall Desk
ModerateFDA (Drugs)·D-0875-2026·Announced 2026-10-07

Zoladex Goserelin Implant Recalled Due to Temperature Abuse

TerSera Therapeutics is recalling 296 cartons of Zoladex (goserelin) implants because the product sat in a non-temperature-controlled trailer for 25.5 hours.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible adverse health consequences. The hazard is a theoretical risk of reduced efficacy due to temperature exposure, with no reported injuries or illnesses.

Plain-English summary

TerSera Therapeutics LLC is recalling 296 cartons of Zoladex (goserelin) implant, 3.6 mg, single-use syringes. The affected product is identified by Lot number YN0099 and has an expiration date of 01/31/2028. The product is distributed nationwide in the United States.

The recall was initiated because the product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours. This temperature abuse may compromise the stability and efficacy of the medication.

Healthcare providers and patients should stop using the affected product and contact TerSera Therapeutics for further instructions or a replacement.

The recalled product

Product
ZOLADEX (GOSERELIN)
Brand
ZOLADEX
Affected units
296

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot#: YN0099
  • Exp 01/31/2028

Distribution

Distributed nationwide across the United States.

Similar recalls